Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1126/science.aar6918 |
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies | |
Zitvogel, Laurence1,2,3,4; Ma, Yuting5,6,7; Raoult, Didier8; Kroemer, Guido9,10,11; Gajewski, Thomas F.12,13 | |
2018-03-23 | |
发表期刊 | SCIENCE
![]() |
ISSN | 0036-8075 |
EISSN | 1095-9203 |
出版年 | 2018 |
卷号 | 359期号:6382页码:1366-1370 |
文章类型 | Review |
语种 | 英语 |
国家 | France; Peoples R China; USA |
英文摘要 | The fine line between human health and disease can be driven by the interplay between host and microbial factors. This "metagenome" regulates cancer initiation, progression, and response to therapies. Besides the capacity of distinct microbial species to modulate the pharmacodynamics of chemotherapeutic drugs, symbiosis between epithelial barriers and their microbial ecosystems has a major impact on the local and distant immune system, markedly influencing clinical outcome in cancer patients. Efficacy of cancer immunotherapy with immune checkpoint antibodies can be diminished with administration of antibiotics, and superior efficacy is observed with the presence of specific gut microbes. Future strategies of precision medicine will likely rely on novel diagnostic and therapeutic tools with which to identify and correct defects in the microbiome that compromise therapeutic efficacy. |
领域 | 地球科学 ; 气候变化 ; 资源环境 |
收录类别 | SCI-E |
WOS记录号 | WOS:000428043600039 |
WOS关键词 | INTESTINAL MICROBIOTA ; CLOSTRIDIUM-DIFFICILE ; ENTEROCOCCUS-HIRAE ; MELANOMA PATIENTS ; GUT MICROBIOTA ; RESISTANCE ; IMMUNITY ; DISEASE ; CYCLOPHOSPHAMIDE ; TRANSPLANTATION |
WOS类目 | Multidisciplinary Sciences |
WOS研究方向 | Science & Technology - Other Topics |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/198239 |
专题 | 地球科学 资源环境科学 气候变化 |
作者单位 | 1.GRCC, Equipe Labellisee Ligue Natl Canc, Villejuif, France; 2.INSERM, U1015, Villejuif, France; 3.Univ Paris Sud, Univ Paris Saclay, Gustave Roussy, Villejuif, France; 4.Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France; 5.Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China; 6.Peking Union Med Coll, Beijing 100005, Peoples R China; 7.Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China; 8.Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Inst Hosp Univ IHU Mediterranee Infect, UM63,CNRS 7278,IRD 198,INSERM 1095, 19-21 Blvd Jean Moulin, F-13005 Marseille, France; 9.Univ Paris 06, Ctr Rech Cordeliers, Univ Paris Descartes, Sorbonne Paris Cite, Paris, France; 10.GRCC, Metabol & Cell Biol Platforms, Villejuif, France; 11.Equipe 11 Labellisee Ligue Natl Canc, UMRS 1138, Paris, France; 12.Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60615 USA; 13.Univ Chicago, Ben May Dept Canc, Chicago, IL 60615 USA |
推荐引用方式 GB/T 7714 | Zitvogel, Laurence,Ma, Yuting,Raoult, Didier,et al. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies[J]. SCIENCE,2018,359(6382):1366-1370. |
APA | Zitvogel, Laurence,Ma, Yuting,Raoult, Didier,Kroemer, Guido,&Gajewski, Thomas F..(2018).The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.SCIENCE,359(6382),1366-1370. |
MLA | Zitvogel, Laurence,et al."The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies".SCIENCE 359.6382(2018):1366-1370. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论